Generation Bio (GBIO) IPO Opens 17% Higher

Today's IPO for Generation Bio Co. (NASDAQ: GBIO) opened for trading at $22.15 announced the pricing of its initial public offering of 10,526,316 shares of its common stock at an initial public offering price of $19.00 per share.

In addition, Generation Bio has granted the underwriters a 30-day option to purchase up to 1,578,947 additional shares of common stock at the initial public offering price, less the underwriting discount and commissions. All of the shares are being offered by Generation Bio.

J.P. Morgan, Jefferies, and Cowen are acting as joint bookrunning managers for the offering. Wedbush PacGrow is acting as lead manager for the offering.

Generation Bio is an innovative genetic medicines company creating a new class of gene therapy.

You May Also Be Interested In